Public Profile

Personalis

Personalis, Inc., a leading player in the genomics industry, is headquartered in the United States, with significant operations across North America and Europe. Founded in 2011, the company has established itself as a pioneer in precision medicine, focusing on advanced genomic sequencing and analysis services. Personalis offers unique solutions, including its proprietary NeXT Personalised Medicine platform, which integrates comprehensive genomic data to provide tailored insights for cancer treatment and research. This innovative approach sets Personalis apart in a competitive market, enabling healthcare providers to make informed decisions based on individual patient profiles. With a strong market position, Personalis has achieved notable milestones, including partnerships with major pharmaceutical companies and contributions to significant clinical trials, solidifying its reputation as a trusted leader in the field of personalised genomics.

DitchCarbon Score

How does Personalis's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

20

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

19

Industry Benchmark

Personalis's score of 20 is higher than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.

76%

Let us know if this data was useful to you

Personalis's reported carbon emissions

Personalis, headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their climate impact or initiatives. However, the absence of emissions data suggests that the company may still be in the process of establishing its climate strategy or reporting framework. As the industry increasingly prioritises sustainability, it is essential for companies like Personalis to develop and communicate clear climate commitments to align with global efforts in reducing carbon footprints.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Personalis's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Personalis is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Personalis is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Predicine, Inc.

US
Health and social work services (85)
Updated 5 days ago

Prenetics Global Limited

HK
Other business services (74)
Updated 5 days ago

Biodesix, Inc.

US
Other business services (74)
Updated 5 days ago

GRAIL, Inc.

US
Health and social work services (85)
Updated 5 days ago

Roche Molecular Systems Inc.

US
Research and development services (73)
Updated 5 days ago
DitchCarbon Score

Guardant Health

US
Research and development services (73)
Updated about 8 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers